Innovative compound kills cancer cells, minimizes damage to normal tissues

[News]

Most of the current clinical anti-tumor drugs used in chemotherapy move around in the patient's blood after intake and are unable to pinpoint the targeted tumor. As a result, while killing the tumor cells, the healthy cells may also be killed as "collateral damage", leading to undesired side effects.

More... (https://www.news-medical.net/news/20191003/Innovative-compound-kills-cancer-cells-minimizes-damage-to-normal-tissues.aspx)